The doping case involving Iga Swiatek has gained additional context with a statement from LEK-AM, the Polish pharmaceutical company that produced the melatonin supplement linked to her positive test. The tennis star, currently serving a one-month suspension for testing positive for the banned substance trimetazidine (TMZ), was found to have ingested the substance through a contaminated batch of the company’s Melatonina LEK-AM 1 mg, used to manage jet lag and sleep issues.
In their statement, LEK-AM expressed deep regret over the situation, both as professionals and as fans of the tennis champion.